Veterinary Biomarker Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Veterinary Biomarker Market is segmented by Animal Type (Companion Animals (Dogs, Cats, and Other Companion Animals) and Farm Animals (Cows, Pigs, and Other Farm Animals), Product Type (Biomarkers, Kits & Reagents, and Biomarker Readers), Application (Disease Diagnostics, Preclinical Research, and Other Applications), Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumors, and Other Disease Types), and Geography (North America (US, Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa GCC, South Africa, and Rest of Middle East and Africa), and South America (Brazil, Argentina, and Rest of South America)). The report offers the value (in USD million) for the above segments.

Veterinary Biomarker Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Veterinary Biomarker Industry Overview

The veterinary biomarker market is fragmented in nature due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known, including Zoetis Inc., Virbac, Veterinary Biomarkers, Inc., ACUVET BIOTECH, Merck & Co., Inc., IDEXX Laboratories, Inc., MI:RNA Diagnostics Ltd, Mercodia AB, Antech Diagnostics, Inc., Avacta Animal Health Limited, and VMRD, Inc.

Veterinary Biomarker Market Leaders

  1. Zoetis Inc.

  2. Virbac

  3. Veterinary Biomarkers, Inc.

  4. ACUVET BIOTECH

  5. Merck & Co., Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Veterinary Biomarker Market Concentration